nitroglycerine

ApprovedSmall molecule

SShaanxi Buchang Pharmaceutical Co., Ltd

nitroglycerine is one of 75 small molecule programs targeting Familial Hemiplegic Migraine. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Familial Hemiplegic MigraineActive, not recruiting

Cardiovascular DiseaseActive, not recruiting

Aortic CoarctationActive, not recruiting

SepsisActive, not recruiting

CholelithiasisActive, not recruiting

Familial Hemiplegic MigrainePreclinical

Active, not recruiting

Cardiovascular DiseasePhase 3

Active, not recruiting

Aortic CoarctationPhase 2

Active, not recruiting

SepsisApproved

Active, not recruiting

CholelithiasisPhase 2

Active, not recruiting

Competition

Competitive Landscape

308 competitors in Sepsis

#DrugCompanyPhaseTrials

nitroglycerine

SShaanxi Buchang Pharmaceutical Co., Ltd

Approved

1 2

Corlanor

Amgen

Preclinical

2 3

Simdax

Orion Corporation, Orion Pharma

Preclinical

1 4

Zyvox

Zemplar

Primaxin

Brevibloc

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

3 8

Levophed

GGeneral Hospital of Ningxia Medical University

Preclinical

2 9

Epsom Salt

FFresenius Kabi Oncology Ltd.

Preclinical

1 10

Aquasol a

BBandim Health Project

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prevention2 trials

Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention

Completed·AAultman Health Foundation·Phase 4·NCT02832115·100 enrolled

Prevention and Comparison of Different Forms of Administration of Nitrates in the Risk of Radial Spasm During Coronary Angiography.

Completed·—·N/A·NCT02258620·442 enrolled

Intravenous2 trials

Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study

Completed·MMahidol University·Phase 4·NCT00707928·100 enrolled

Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine

Unknown status·SSohag University·N/A·NCT06265415·60 enrolled

Aortic Coarctation1 trial

Effect of Strategy for Blood Pressure Control on Cerebral Oxygen Balance During Aortic Coarctation Repair: A Randomized Study

Completed·UUniversity Hospital, Ghent·Phase 2·NCT00535808·30 enrolled

Chronic Stable Angina1 trial

Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina

Unknown status·SShaanxi Buchang Pharmaceutical Co., Ltd·Phase 4·NCT02280850·300 enrolled

ART1 trial

The Effect of Periradial Injection of Papaverine Versus Nitroglycerine on Radial Artery Diameter

Completed·KKasr El Aini Hospital·Phase 1·NCT04030663·90 enrolled

7 more indications

Hypotensive Anesthesia1 trial

Effect of Local Anesthesia Versus Induced Hypotensive Anesthesia on Quality of External Dacryocystorhinostomy Operation

Unknown status·MMansoura University·N/A·NCT05241054·64 enrolled

Side Effects1 trial

Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline

Terminated·YYaakov Beilin·Phase 2/3·NCT02115256·6 enrolled

Stellate Ganglion Block1 trial

Effect of Stellate Ganglion Block on Internal Mammary Artery Dynamics

Completed·—·N/A·NCT05952011·70 enrolled

Cholelithiasis1 trial

Treatment of Suspected Cholelithiasis With Nitroglycerin

Unknown status·UUnited States Naval Medical Center, San Diego·Phase 2·NCT01715220·62 enrolled

Cardiovascular Disease1 trial

PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease

Completed·UUniversity of Michigan·Phase 3·NCT00554853·143 enrolled

Familial Hemiplegic Migraine1 trial

Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine

Completed·DDanish Headache Center·N/A·NCT00541736·30 enrolled

Sepsis1 trial

Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis

Unknown status·OOnze Lieve Vrouwe Gasthuis·Phase 4·NCT00484133·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 14 trial records for nitroglycerine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — nitroglycerine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for nitroglycerine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shaanxi Buchang Pharmaceutical Co., Ltd company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: SShaanxi Buchang Pharmaceutical Co., Ltd

nitroglycerine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Prevention2 trials

Intravenous2 trials

Aortic Coarctation1 trial

Chronic Stable Angina1 trial

ART1 trial

Hypotensive Anesthesia1 trial

Side Effects1 trial

Stellate Ganglion Block1 trial

Cholelithiasis1 trial

Cardiovascular Disease1 trial

Familial Hemiplegic Migraine1 trial

Sepsis1 trial

References

Drug Info

Quick Facts

Related News